Equillium (EQ) Competitor Comparison
We are evaluating the key criteria listed to compare Equillium (EQ) against its competitors in the Biotechnology industry.
Market Capitalization
268 / 368Gross Profits
90 / 278Total Revenue
130 / 300EBITDA
55 / 337Free Cashflow
28 / 352Quick Ratio
297 / 357Earnings per Share
63 / 359Dividend yield
0 / 6Total Cash
261 / 358Performance 3 years
250 / 368Performance 5 years
239 / 368Performance 10 years
270 / 368Linearity 3 years
248 / 368Linearity 5 years
185 / 368Linearity 10 years
259 / 368Total Rank
118 / 368Dividend Rank
121 / 368Valuation Rank
41 / 368Piotroski Rank
112 / 368Muliplier Rank
54 / 368Linearity 10 years - EQ ranking 259 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.